Literature DB >> 833431

Solid phase radioimmunoassay using labelled antibodies: a conceptual framework for designing assays.

J Kalmakoff, A J Parkinson, A M Crawford, B R Williams.   

Abstract

A simple theoretical model for the antigen-antibody reaction is presented ans used to evaluate the optimum conditions for designing solid phase radioimmunoassay (RIA) using labelled antibodies. Both theoretical and experimental data are presented, using a wide variety of antigens and their corresponding antibodies. The types of RIA is described include the direct, the indirect, sandwich assays for detecting either antigen or antibody. The experimental results confirm in a semiquantitative manner that the greatest sensitivity of the RIA is achieved when the smallest amount of labelled antibody is used, that whenever possible the antigen/antibody ratio should be greater than unity (greater than 1), and that the formation of the antigen-antibody comples is dependent on the mass action effect.

Mesh:

Substances:

Year:  1977        PMID: 833431     DOI: 10.1016/s0022-1759(97)90024-7

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  4 in total

1.  Comparison of solid-phase radioimmunoassays for baculoviruses.

Authors:  A M Crawford; P Faulkner; J Kalmakoff
Journal:  Appl Environ Microbiol       Date:  1978-07       Impact factor: 4.792

2.  Affinity-purified antibodies of defined specificity for use in a solid-phase microplate radioimmunoassay of human Tamm-Horsfall glycoprotein in urine.

Authors:  J S Hunt; A R McGiven; A Groufsky; K L Lynn; M C Taylor
Journal:  Biochem J       Date:  1985-05-01       Impact factor: 3.857

3.  Effect of alkaline protease on the antigenic nature of wiseana nuclear polyhedrosis virus polyhedron protein.

Authors:  A M Crawford; J Kalmakoff
Journal:  J Virol       Date:  1977-10       Impact factor: 5.103

4.  Immunoglobulin production in vitro by peripheral blood lymphocytes in systemic lupus erythematosus: helper T cell defect and B cell hyperreactivity.

Authors:  P Tan; G Pang; J D Wilson
Journal:  Clin Exp Immunol       Date:  1981-06       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.